Results 221 to 230 of about 5,917,592 (236)

CA125 is Superior to CA19-9 in Predicting the Resectability of Pancreatic Cancer

Journal of Gastrointestinal Surgery, 2013
Zhiwen Xiao, Xianjun Yu, Guopei Luo
exaly  

[CA19-9].

Nihon rinsho. Japanese journal of clinical medicine, 2000
openaire   +1 more source

Study on the mechanism causing elevation of serum CA19-9 levels in diabetic patients

Endocrine Journal, 2013
Masafumi Koga, Yoshifumi Saisho, Jun Murai   +2 more
exaly  

ASSESSMENT OF CA125 AND CA19-9 IN SILICOSIS

2014
Kübranur Ünal, Bal, Ceylan Demir, Yılmaz, Ömer Hınç, Tutkun, Engin, Yilmaz, Fatma Meric   +4 more
openaire   +1 more source

CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype

Cancer Letters, 2017
Chen Liu, Zhiwen Xiao, Xianjun Yu
exaly  

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

British Journal of Cancer, 2005
M A Tempero, J L Abbruzzese, E K Bergsland   +2 more
exaly  

[CA19-9].

Nihon rinsho. Japanese journal of clinical medicine, 2005
openaire   +1 more source

[Lewis antigens and CA19-9].

Nihon rinsho. Japanese journal of clinical medicine, 1998
K, Naka, N, Shimojo
openaire   +1 more source

Marked Elevation of Serum CA19-9 and Stomach Carcinoma

Oncology, 1998
Y, Horie, K, Matsui, A, Shigoku, A, Yukimasa, K, Miura, A, Hosoda, T, Hamamoto, H, Kawasaki   +7 more
openaire   +2 more sources

Elevated baseline CA19-9 levels correlate with adverse prognosis in patients with early- or advanced-stage pancreas cancer

Medical Oncology, 2012
Tanios Bekaii-Saab
exaly